Clinical Trials Browser

Phase 2 × Unknown × vandetanib × Clear all

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Phase 2 Unknown

Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT02530411 2015-08-21

FURVA

Phase 2 Unknown

Neoplasms